4D Molecular Therapeutics FDMT
NASDAQ FDMT
$12.45 -0.17 (-1.35%)
As of: Oct 22, 2026 · 12:34 PM EDT

4D Molecular Therapeutics (FDMT) Debt Ratio (2026)

Updated

4D Molecular Therapeutics' Debt Ratio was 0.04 in Q2 2026.

Analysis

4D Molecular Therapeutics (FDMT) Debt Ratio (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,174.91 Bn 1,143.49 Bn 19.71 Bn 0.39
2 Johnson & Johnson 644.40 Bn 562.93 Bn 17.26 Bn 0.24
3 AbbVie 503.86 Bn 476.97 Bn 12.70 Bn 0.52
4 Merck 379.74 Bn 334.12 Bn 12.21 Bn 0.42
5 Novartis Ag 303.49 Bn 267.48 Bn 11.24 Bn 0.08
6 Astrazeneca 269.36 Bn 243.04 Bn 12.86 Bn 0.28
7 Amgen 243.43 Bn 198.83 Bn 7.24 Bn 0.60
8 Gilead Sciences 194.04 Bn 168.24 Bn 6.22 Bn 0.53
9 Pfizer 172.94 Bn 119.58 Bn 10.94 Bn 0.31
10 4D Molecular Therapeutics 882.27 Mn -577.68 Mn - 0.04
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.04
API Access

4D Molecular Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=FDMT&period=max&api_key=YOUR_API_KEY